Synucleins: Are they two‐edged swords?

The synuclein family consists of three distinct highly homologous genes, α‐synuclein, β‐synuclein, and γ‐synuclein, which have so far been found only in vertebrates. Proteins encoded by these genes are characterized by an acidic C‐terminal region and five or six imperfect repeat motifs (KTKEGV) distributed throughout the highly conserved N‐terminal region. Numerous data demonstrate that synucleins are implicated in two groups of the most devastating human disorders, i.e., neurodegenerative diseases (NDDs) and cancer. Mutations in the α‐synuclein gene are associated with familial forms of Parkinson's disease (PD), and accumulation of α‐synuclein inclusions is a hallmark of this disorder. In breast cancer, increased expression of γ‐synuclein correlates with disease progression. Conversely, some results indicate that the members of the synuclein family may have a protective effect. How might these small proteins combine such controversial properties? We present evidence that synuclein's features are basically regulated by two mechanisms, i.e., posttranslational modifications (PTMs) and the level of their expression. We also discuss a new, emerging area of investigation of synucleins, namely, their role in the cell‐to‐cell propagation of pathology. © 2012 Wiley Periodicals, Inc.